albuquerque 1

NANETS Regional NET Education: The Multidisciplinary Management of NET Disease

CME/CE Certified Activity
Saturday, November 2, 2019

7:30am – 4:00pm 

6.25 AMA PRA Category 1 Credits.™

REGISTER HERE

Location

Sheraton Albuquerque Uptown

2600 Louisiana Blvd. N.E.

Albuquerque, NM 87110

Providers

Jointly Provided by The University of New Mexico, Comprehensive Cancer Center

Course Directors

Heloisa Soares, MD, PhD, University of New Mexico
Joanna Fair, MD, PhD, University of New Mexico

Overview

Neuroendocrine tumors (NET) are considered to be a rare disease although the frequency of diagnosis has increased over the last ten years. As this is a rare disease, clinicians often do not know how to implement the appropriate care plan and until the last ten years, there was great variability in terms of treatment. The diagnosis, treatment and management of NETs are time-consuming, complex and require a multidisciplinary approach. Many healthcare providers who face these challenges are not adequately equipped in their knowledge or experience optimally manage NET disease.

The field of NET research has been evolving with new drug approvals and treatment modalities. In addition, experts in the field of NET disease have continued to develop strategies to improve diagnosis, treatment and management of NET cancers. It is through convening professionals in the areas of oncology, gastroenterology, pulmonology, surgery, radiology and allied fields that the awareness and understanding of NET diseases will expand, resulting in better treatment for NET patients.

Target Audience

This activity is designed for oncologists, gastroenterologists, pulmonologists, surgeons, radiologists, pathologists, primary care physicians, advanced practice nurses, nurses, physician assistants, pharmacists, fellows, students, and other allied health professionals involved with or interested in the treatment of patients with neuroendocrine tumors.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Review current concepts of neuroendocrine tumor pathology, molecular profile, classification, and grading
  • Discuss the various diagnostic processes and use of current and emerging diagnostic tools to determine neuroendocrine tumor type
  • Summarize the current safety and efficacy data of the various surgical, medical and loco-regional approaches in the management of neuroendocrine tumors
  • Recognize the clinical features associated with carcinoid syndrome
  • Apply a multidisciplinary approach to the management of patients with neuroendocrine tumors
  • Review clinical trial data and ongoing studies evaluating novel management strategies for the treatment of neuroendocrine tumors

Program

7:30 - 8:00     Registration & Breakfast

8:00 - 8:10     Welcome and Opening Remarks --- Heloisa Soares, MD, University of New Mexico and Joanna Fair, MD, University of New Mexico

8:10 - 9:30     Overview of Neuroendocrine Tumors

  • Background, Epidemiology, Symptoms, Biochemical Diagnosis and Pathology of NETs --- Erika Maestas, MD, UNM
  • Pathology of NETs: General Features, Grade, Staging, Sites --- David Martin, MD, UNM
  • Endoscopic Diagnosis and Management of NETs --- Gulshan Parasher, MD, UNM

9:30 - 10:45   Surgical Treatment of NETs

  • Surgical Principles in SBNETs: Primary, Nodes, Metastases --- Eric Liu, MD, Rocky Mountain Cancer Center
  • Surgical principles in PNETs --- Eric Liu, MD, Rocky Mountain Cancer Center
  • Surgery for Gastric, Duodenal, and Colorectal NETs ---Bridget Fahy, MD, UNM
  • Principles of Hepatic Cytoreduction - Itzak Nir, MD, UNM
  • Panel: Question and Answer 

10:45 - 11:00 Break

11:00 - 11:30 Hormonal Management of NETs

  • Hormonal syndromes in NETs, functional PNETs --- Boris Naraev, MD, PhD, FACP, Banner MD Anderson Cancer Center
  • Symptom Control in NETs --- Boris Naraev, MD, PhD, FACP, Banner MD Anderson Cancer Center

11:30 - 12:15 Medical Management of NETs

  • Overview of Clinical Trials and Agents used in NETs --- Thorvardur  Halfdanarson, MD, Mayo Clinic
  • Treatment of Progressive and Poorly-differentiated NETs --- Heloisa Soares, MD, UNM
  • Panel: Question and Answer session for Hormonal and Medical Management

12:15-1:00     Lunch

1:00 - 2:00 pm   Radiology Management of NET

  • Review of Current Imaging Modalities in NET --- Shana Elman, MD, UNM
  • PRRT in the treatment of NET—Joanna Fair, MD, UNM
  • Imaging Modalities and Interventional Management of NET --- Christopher Gutjar, MD, UNM

2:00 to 2:30  Additional Important Subjects in NETs

  • Hereditary syndromes with NETs: MEN1/2, VHL, Pheochromocytoma/Paraganglioma – Anthony Heaney, MD, UCLA
  •  Pulmonary NETs: Clinical features, medical and surgical treatment – Thorvardur Halfdanarson, MD, Mayo Clinic
  •  Carcinoid Heart Disease – Bernard Tawfik, MD, UNM

2:30 - 3:30     Case Presentations and Multidisciplinary Tumor Board

ACCREDITATION

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of New Mexico Office of Continuing Medical Education and North American Neuroendocrine Tumor Society. The University of New Mexico Office of Continuing Medical Education is accredited by the ACCME to provide continuing medical education for physicians. The Office of Continuing Medical Education designates this educational activity for a maximum of 6.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

REGISTER 

In-person registration is available onsite the day of the program and will be accommodated on a space-available basis

Registration fee:

NANETS Member

$65 - MD, PharmD, Doctoral Level 
$35 - Allied Health
Complimentary - Student/Fellow/Resident

Non-Member

$95 - MD, PharmD, Doctoral Level 
$50 - Allied Health
Complimentary - Student/Fellow/Resident

Cancellation Policy:

A full refund will be made if registration is canceled, in writing, on or before October 27, 2019. On or after October 28, 2019, no refund will be made.

The University of New Mexico, Comprehensive Cancer Center and the North American Neuroendocrine Tumor Society reserve the right to modify the activity content, faculty, and activities and reserve the right to cancel this activity if necessary. If the program is cancelled, liability is limited to the registration fee.

Questions?

Please contact us with any questions.